BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 10051535)

  • 1. Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells.
    Parker WB; Shaddix SC; Rose LM; Shewach DS; Hertel LW; Secrist JA; Montgomery JA; Bennett LL
    Mol Pharmacol; 1999 Mar; 55(3):515-20. PubMed ID: 10051535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemoenzymatic synthesis of clofarabine and related 2'-deoxyfluoroarabinosyl nucleosides: the electronic and stereochemical factors determining substrate recognition by E. coli nucleoside phosphorylases.
    Fateev IV; Antonov KV; Konstantinova ID; Muravyova TI; Seela F; Esipov RS; Miroshnikov AI; Mikhailopulo IA
    Beilstein J Org Chem; 2014; 10():1657-69. PubMed ID: 25161724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-dependent Differences in Liver and Gut Metabolomic Profiles With Acarbose and Calorie Restriction in C57BL/6 Mice.
    Gibbs VK; Brewer RA; Miyasaki ND; Patki A; Smith DL
    J Gerontol A Biol Sci Med Sci; 2018 Jan; 73(2):157-165. PubMed ID: 28651373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrow Contraction and Expansion in Tropical Diagrams.
    Matveev R; Portegies JW
    Entropy (Basel); 2023 Dec; 25(12):. PubMed ID: 38136517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective.
    Ali SS; Raj R; Kaur T; Weadick B; Nayak D; No M; Protos J; Odom H; Desai K; Persaud AK; Wang J; Govindarajan R
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aza-4'-thio-2'-deoxycytidine, a New Orally Bioavailable Nontoxic "Best-in-Class": DNA Methyltransferase 1-Depleting Agent in Clinical Development.
    Parker WB; Thottassery JV
    J Pharmacol Exp Ther; 2021 Nov; 379(3):211-222. PubMed ID: 34503994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-guided design of anti-cancer ribonucleotide reductase inhibitors.
    Misko TA; Liu YT; Harris ME; Oleinick NL; Pink J; Lee HY; Dealwis CG
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):438-450. PubMed ID: 30734609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugar modified pyrimido[4,5-
    Konč J; Tichý M; Pohl R; Hodek J; Džubák P; Hajdúch M; Hocek M
    Medchemcomm; 2017 Sep; 8(9):1856-1862. PubMed ID: 30108897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators.
    Ahmad MF; Huff SE; Pink J; Alam I; Zhang A; Perry K; Harris ME; Misko T; Porwal SK; Oleinick NL; Miyagi M; Viswanathan R; Dealwis CG
    J Med Chem; 2015 Dec; 58(24):9498-509. PubMed ID: 26488902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.
    Cooper TM; Alonzo TA; Gerbing RB; Perentesis JP; Whitlock JA; Taub JW; Horton TM; Gamis AS; Meshinchi S; Loken MR; Razzouk BI
    Cancer; 2014 Aug; 120(16):2482-9. PubMed ID: 24771494
    [TBL] [